Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder Article

Durell, Todd M, Pumariega, Andres J, Rothe, Eugenio M et al. (2009). Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder . ANNALS OF CLINICAL PSYCHIATRY, 21(1), 26-37.

International Collaboration

cited authors

  • Durell, Todd M; Pumariega, Andres J; Rothe, Eugenio M; Tamayo, Jorge M; Baron, David; Williams, David

sustainable development goals

authors

publication date

  • February 1, 2009

webpage

published in

keywords

  • ADHD
  • ADULTS
  • AGE
  • African-American
  • CHILDREN
  • Caucasian
  • DIAGNOSIS
  • DOUBLE-BLIND
  • ETHNICITY
  • HYPERACTIVITY
  • Life Sciences & Biomedicine
  • METHYLPHENIDATE
  • Psychiatry
  • Science & Technology
  • VALIDITY
  • atomoxetine
  • attention-deficit/hyperactivity disorder
  • race

publisher

  • QUADRANT HEALTHCOM INC

start page

  • 26

end page

  • 37

volume

  • 21

issue

  • 1